Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 18 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

6%

1 trials in Phase 3/4

Results Transparency

31%

5 of 16 completed trials have results

Key Signals

5 with results

Enrollment Performance

Analytics

Phase 1
6(46.2%)
Phase 2
5(38.5%)
Phase 3
1(7.7%)
N/A
1(7.7%)
13Total
Phase 1(6)
Phase 2(5)
Phase 3(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (18)

Showing 18 of 18 trials
NCT04881942Not ApplicableCompleted

Characterization of Selected Aerosol Constituents Levels in the Exhaled Breath of Adult e-Vapor Users

Role: collaborator

NCT03186378Phase 2Completed

Evaluation of Systemic Exposure to VP-102 in Subjects With Molluscum Contagiosum.

Role: collaborator

NCT01597401Phase 1Completed

A Single Dose Study of the Safety, Blood Levels and Biological Effects of Aes-103 Compared to Placebo in Subjects With Stable Sickle Cell Disease

Role: collaborator

NCT02506179Completed

Impact of Adalimumab on Patient-reported Outcomes in Ulcerative Colitis

Role: collaborator

NCT01387802Completed

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Role: collaborator

NCT01559038Completed

Canadian Humira Post Marketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis

Role: collaborator

NCT02232893Phase 2Completed

Effect of TU-100 in Patients Undergoing Laparoscopic Colectomy

Role: collaborator

NCT01387815Completed

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Psoriasis

Role: collaborator

NCT02581189Completed

Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Canada

Role: collaborator

NCT02602184Phase 2Unknown

Safety and Efficacy of AR/101 in Accelerating Re-epithelialization of Split Thickness Wounds

Role: collaborator

NCT01890837Phase 1Completed

Effect of TU-100 in Patients With Irritable Bowel Syndrome (IBS)

Role: collaborator

NCT00765700Phase 3Completed

Ketoprofen 10% Cream for Treatment of Pain Associated With Mild to Moderate Acute Soft Tissue Injury

Role: collaborator

NCT01348152Phase 2Completed

Effect of TU-100 in Patients With Functional Constipation

Role: collaborator

NCT00926068Phase 2Unknown

Safety and Efficacy of HO/03/03 10μg in the Treatment of Plantar Neuropathic Diabetic Foot Ulcers

Role: collaborator

NCT00871325Phase 1Completed

Effect of TU-100 on Gastrointestinal and Colonic Transit in Humans

Role: collaborator

NCT01139216Phase 1Completed

Effect of TU-100 on Rectal Compliance, Rectal Sensation and Small Bowel and Colonic Transit in Females With Constipation

Role: collaborator

NCT01483846Phase 1Completed

Safety, Tolerability and Pharmacokinetics of Multiple Doses of AV-101 in Healthy Volunteers

Role: collaborator

NCT00677859Phase 1Completed

Safety Study of MultiStem® in Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplasia

Role: collaborator

All 18 trials loaded